Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Simulation of Drug Release from PLGA Particles In Vivo.

Sasaki K, Igarashi M, Hinata M, Komori Y, Fukushima K.

J Drug Deliv. 2013;2013:513950. doi: 10.1155/2013/513950. Epub 2013 Oct 10.

2.

[Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].

Miao LF, Yang J, Huang CL, Song CX, Zeng YJ, Chen LF, Zhu WL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):491-7. Chinese.

3.

Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.

Wang H, Liu J, Tao S, Chai G, Wang J, Hu FQ, Yuan H.

Int J Nanomedicine. 2015 Sep 8;10:5671-85. doi: 10.2147/IJN.S88798. eCollection 2015.

4.

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading.

Han FY, Thurecht KJ, Whittaker AK, Smith MT.

Front Pharmacol. 2016 Jun 28;7:185. doi: 10.3389/fphar.2016.00185. eCollection 2016. Review.

5.

Engineered nanomedicine for myeloma and bone microenvironment targeting.

Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, Bertrand N, Lu ZN, Nagano K, Baron R, Sacco A, Roccaro AM, Farokhzad OC, Ghobrial IM.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10287-92. doi: 10.1073/pnas.1401337111. Epub 2014 Jun 30.

6.

Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.

Jiang T, Yu X, Carbone EJ, Nelson C, Kan HM, Lo KW.

Int J Pharm. 2014 Nov 20;475(1-2):547-57. doi: 10.1016/j.ijpharm.2014.08.067. Epub 2014 Sep 4.

PMID:
25194353
7.

A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells.

Bai MY, Liu SZ.

Colloids Surf B Biointerfaces. 2014 May 1;117:346-53. doi: 10.1016/j.colsurfb.2014.02.051. Epub 2014 Mar 12.

PMID:
24681046
8.

Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.

Xu P, Gullotti E, Tong L, Highley CB, Errabelli DR, Hasan T, Cheng JX, Kohane DS, Yeo Y.

Mol Pharm. 2009 Jan-Feb;6(1):190-201. doi: 10.1021/mp800137z.

9.

A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.

Xu W, Wei X, Wei K, Cao X, Zhong S.

Int J Pharm. 2014 Dec 10;476(1-2):116-23. doi: 10.1016/j.ijpharm.2014.09.040. Epub 2014 Sep 28.

PMID:
25271077
10.

Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.

Park JH, Lee JY, Termsarasab U, Yoon IS, Ko SH, Shim JS, Cho HJ, Kim DD.

Int J Pharm. 2014 Oct 1;473(1-2):426-33. doi: 10.1016/j.ijpharm.2014.07.038. Epub 2014 Jul 28.

PMID:
25079433
11.

Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).

Frauke Pistel K, Breitenbach A, Zange-Volland R, Kissel T.

J Control Release. 2001 May 18;73(1):7-20.

PMID:
11337055
12.

The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.

Samadi N, Abbadessa A, Di Stefano A, van Nostrum CF, Vermonden T, Rahimian S, Teunissen EA, van Steenbergen MJ, Amidi M, Hennink WE.

J Control Release. 2013 Dec 10;172(2):436-43. doi: 10.1016/j.jconrel.2013.05.034. Epub 2013 Jun 7.

PMID:
23751568
13.

The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.

Simon LC, Sabliov CM.

Drug Metab Rev. 2014 May;46(2):128-41. doi: 10.3109/03602532.2013.864664. Epub 2013 Dec 5. Review.

PMID:
24303927
14.

Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).

Chen Y, Yang Z, Liu C, Wang C, Zhao S, Yang J, Sun H, Zhang Z, Kong D, Song C.

Int J Nanomedicine. 2013;8:4315-26. doi: 10.2147/IJN.S51629. Epub 2013 Nov 7.

15.
16.

Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.

Liu R, Wang Y, Li X, Bao W, Xia G, Chen W, Cheng J, Xu Y, Guo L, Chen B.

Drug Des Devel Ther. 2015 May 22;9:2705-19. doi: 10.2147/DDDT.S80948. eCollection 2015.

17.

Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.

Mistry NP, Desai JL, Thakkar HP.

J Pharm Pharmacol. 2015 Oct;67(10):1337-48. doi: 10.1111/jphp.12430. Epub 2015 May 5.

PMID:
25944126
18.

Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells.

Situ JQ, Ye YQ, Zhu XL, Yu RS, You J, Yuan H, Hu FQ, Du YZ.

Int J Nanomedicine. 2015 Jan 17;10:665-75. doi: 10.2147/IJN.S76307. eCollection 2015.

19.

A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.

Liu J, Meisner D, Kwong E, Wu XY, Johnston MR.

Biomaterials. 2007 Jul;28(21):3236-44. Epub 2007 Mar 24.

PMID:
17434581
20.

Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.

Seju U, Kumar A, Sawant KK.

Acta Biomater. 2011 Dec;7(12):4169-76. doi: 10.1016/j.actbio.2011.07.025. Epub 2011 Jul 30.

PMID:
21839863

Supplemental Content

Support Center